Page last updated: 2024-10-17

aminocaproic acid and Breast Neoplasms

aminocaproic acid has been researched along with Breast Neoplasms in 3 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Liao, TT1
Han, JF1
Zhang, FY1
Na, R1
Ye, WL1
Viedma-Rodríguez, R1
Martínez-Hernández, MG1
Flores-López, LA1
Baiza-Gutman, LA1
Zhao, R1
Liang, X1
Zhao, B1
Chen, M1
Liu, R1
Sun, S1
Yue, X1
Wang, S1

Other Studies

3 other studies available for aminocaproic acid and Breast Neoplasms

ArticleYear
Enhanced Anti-Tumor Effect of Folate-Targeted FA-AMA-hyd-DOX Conjugate in a Xenograft Model of Human Breast Cancer.
    Molecules (Basel, Switzerland), 2021, Nov-24, Volume: 26, Issue:23

    Topics: Aminocaproic Acid; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Dru

2021
Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system.
    Molecular and cellular biochemistry, 2018, Volume: 437, Issue:1-2

    Topics: Aminocaproic Acid; Breast Neoplasms; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Gl

2018
Ultrasound assisted gene and photodynamic synergistic therapy with multifunctional FOXA1-siRNA loaded porphyrin microbubbles for enhancing therapeutic efficacy for breast cancer.
    Biomaterials, 2018, Volume: 173

    Topics: Aminocaproic Acid; Animals; Apoptosis; Breast Neoplasms; Combined Modality Therapy; Female; Genetic

2018